Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;76:645-653

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.-X.
Right arrow Articles by Korth, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.-X.
Right arrow Articles by Korth, M.
(Circulation Research. 1995;76:645-653.)
© 1995 American Heart Association, Inc.


Articles

Effects of Doxorubicin on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocardium

Yong-Xiao Wang, Michael Korth

From the Institut für Pharmakologie und Toxikologie der Technischen, Universität München (Germany).

Correspondence to Dr Michael Korth, Institut für Pharmakologie und Toxikologie der Technischen, Universität München, Biedersteiner Str 29, D-80802 München, Germany.

Abstract Doxorubicin, an anticancer drug, was recently shown to release Ca2+ from cardiac sarcoplasmic reticulum (SR) by increasing the open probability of Ca2+ release channels. In the present study, we investigated the effects of doxorubicin on excitation-contraction coupling of guinea pig heart preparations. In papillary muscles contracting at 0.5 Hz, 100 µmol/L doxorubicin produced within 3 hours the following effects: it increased the force of contraction by 269.3±19.8% (n=6) and prolonged the time to peak force by 75.1±8.7% (n=6), relaxation time by 54.7±8.7% (n=6), and action potential duration (APD) at 90% repolarization (APD90) by 38.6±2.9% (n=3). Despite its positive inotropic effect, doxorubicin depressed the early contraction component by increasing the latency between stimulus and the onset of force development. In single myocytes, 100 µmol/L doxorubicin prolonged APD90 by 62.1% (n=18) and blocked time-dependent delayed rectifier K+ current (IK) by 44% (n=9). Ca2+ inward current and inward rectifier K+ current were not affected by doxorubicin. Ca2+ transients elicited in myocytes loaded with the fluorescent Ca2+ indicator fura 2 were strongly suppressed by doxorubicin in their initial rising phase. Thereafter, doxorubicin produced a delayed rise in intracellular Ca2+, which reached a late peak exceeding that of the control peak by 52±8% (n=5). The results suggest that doxorubicin decreases Ca2+-induced Ca2+ release from cardiac SR, probably by increasing the SR Ca2+ leak. On the other hand, prolongation of APD due to inhibition of IK allows more Ca2+ to enter the cell. After being only temporarily buffered by the SR, Ca2+ may accumulate in the cytosol as long as depolarization is maintained and lead to a more complete activation of contractile proteins.


Key Words: doxorubicin • ventricular myocytes • positive inotropic effect • sarcoplasmic reticulum Ca2+ release • action potential




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. J. Choi, M. R. Seon, S. S. Lim, J.-S. Kim, H. S. Chun, and J. H. Y. Park
Hexane/Ethanol Extract of Glycyrrhiza uralensis Licorice Suppresses Doxorubicin-Induced Apoptosis in H9c2 Rat Cardiac Myoblasts
Experimental Biology and Medicine, December 1, 2008; 233(12): 1554 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Deng, B. Kulle, M. Hosseini, G. Schluter, G. Hasenfuss, L. Wojnowski, and A. Schmidt
Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity
Eur J Heart Fail, October 1, 2007; 9(10): 986 - 994.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. Rudzinski, M. Ciesielczyk, W. Religa, Z. Bednarkiewicz, and M. Krzeminska-Pakula
Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator
Europace, May 1, 2007; 9(5): 278 - 280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. De Jongh, V. Ramanathan, B. K. Hoffmeister, and R. A. Malkin
Left ventricular geometry immediately following defibrillation: shock-induced relaxation
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H815 - H819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y.-X. Wang, Y.-M. Zheng, I. Abdullaev, and M. I. Kotlikoff
Metabolic inhibition with cyanide induces calcium release in pulmonary artery myocytes and Xenopus oocytes
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C378 - C388.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Nakamura, Y. Ueda, Y. Juan, S. Katsuda, H. Takahashi, and E. Koh
Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats : In Vivo Study
Circulation, August 1, 2000; 102(5): 572 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-X. Wang, X.-B. Zhou, and M. Korth
Effects of Mitoxantrone on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 501 - 508.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
P Venditti, M Balestrieri, T De Leo, and S Di Meo
Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres
Cardiovasc Res, June 1, 1998; 38(3): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]